ID   CGL_RAT                 Reviewed;         398 AA.
AC   P18757;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   02-OCT-2024, entry version 162.
DE   RecName: Full=Cystathionine gamma-lyase;
DE            Short=CGL;
DE            Short=CSE;
DE            EC=4.4.1.1 {ECO:0000305|PubMed:13525371, ECO:0000305|PubMed:6456763};
DE   AltName: Full=Cysteine desulfhydrase;
DE   AltName: Full=Cysteine-protein sulfhydrase;
DE   AltName: Full=Gamma-cystathionase;
DE   AltName: Full=Homocysteine desulfhydrase;
DE            EC=4.4.1.2 {ECO:0000250|UniProtKB:P32929};
DE   AltName: Full=Probasin-related antigen;
DE            Short=PRB-RA;
GN   Name=Cth;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8288556; DOI=10.1016/s0021-9258(17)42213-7;
RA   Nishi N., Tanabe H., Oya H., Urushihara M., Miyanaka H., Wada F.;
RT   "Identification of probasin-related antigen as cystathionine gamma-lyase by
RT   molecular cloning.";
RL   J. Biol. Chem. 269:1015-1019(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-398, AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=2201285; DOI=10.1042/bj2690335;
RA   Erickson P.F., Maxwell I.H., Su L.J., Baumann M., Glode L.M.;
RT   "Sequence of cDNA for rat cystathionine gamma-lyase and comparison of
RT   deduced amino acid sequence with related Escherichia coli enzymes.";
RL   Biochem. J. 269:335-340(1990).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=13525371; DOI=10.1016/s0021-9258(18)70476-6;
RA   Matsuo Y., Greenberg D.M.;
RT   "A crystalline enzyme that cleaves homoserine and cystathionine. I.
RT   Isolation procedure and some physicochemical properties.";
RL   J. Biol. Chem. 230:545-560(1958).
RN   [4]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=6456763; DOI=10.1021/bi00518a039;
RA   Esaki N., Nakamura T., Tanaka H., Suzuki T., Morino Y., Soda K.;
RT   "Enzymatic synthesis of selenocysteine in rat liver.";
RL   Biochemistry 20:4492-4496(1981).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Catalyzes the last step in the trans-sulfuration pathway from
CC       L-methionine to L-cysteine in a pyridoxal-5'-phosphate (PLP)-dependent
CC       manner, which consists on cleaving the L,L-cystathionine molecule into
CC       L-cysteine, ammonia and 2-oxobutanoate (Probable) (PubMed:13525371).
CC       Part of the L-cysteine derived from the trans-sulfuration pathway is
CC       utilized for biosynthesis of the ubiquitous antioxidant glutathione.
CC       Besides its role in the conversion of L-cystathionine into L-cysteine,
CC       it utilizes L-cysteine and L-homocysteine as substrates (at much lower
CC       rates than L,L-cystathionine) to produce hydrogen sulfide (H2S). In
CC       vitro, it converts two L-cysteine molecules into lanthionine and H2S,
CC       and two L-homocysteine molecules to homolanthionine and H2S, which can
CC       be particularly relevant under conditions of severe
CC       hyperhomocysteinemia. Lanthionine and homolanthionine are structural
CC       homologs of L,L-cystathionine that differ by the absence or presence of
CC       an extra methylene group, respectively. Acts as a cysteine-protein
CC       sulfhydrase by mediating sulfhydration of target proteins:
CC       sulfhydration consists of converting -SH groups into -SSH on specific
CC       cysteine residues of target proteins such as GAPDH, PTPN1 and NF-kappa-
CC       B subunit RELA, thereby regulating their function. By generating the
CC       gasotransmitter H2S, it participates in a number of physiological
CC       processes such as vasodilation, bone protection, and inflammation (By
CC       similarity). Plays an essential role in myogenesis by contributing to
CC       the biogenesis of H2S in skeletal muscle tissue (By similarity). Can
CC       also accept homoserine as substrate (PubMed:13525371). Catalyzes the
CC       elimination of selenocystathionine (which can be derived from the diet)
CC       to yield selenocysteine, ammonia and 2-oxobutanoate (Probable).
CC       {ECO:0000250|UniProtKB:P32929, ECO:0000250|UniProtKB:Q8VCN5,
CC       ECO:0000269|PubMed:13525371, ECO:0000305|PubMed:6456763}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L,L-cystathionine = 2-oxobutanoate + L-cysteine +
CC         NH4(+); Xref=Rhea:RHEA:14005, ChEBI:CHEBI:15377, ChEBI:CHEBI:16763,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:35235, ChEBI:CHEBI:58161; EC=4.4.1.1;
CC         Evidence={ECO:0000269|PubMed:13525371, ECO:0000305|PubMed:6456763};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14006;
CC         Evidence={ECO:0000269|PubMed:13525371, ECO:0000305|PubMed:6456763};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-homoserine = 2-oxobutanoate + NH4(+); Xref=Rhea:RHEA:24923,
CC         ChEBI:CHEBI:16763, ChEBI:CHEBI:28938, ChEBI:CHEBI:57476; EC=4.4.1.1;
CC         Evidence={ECO:0000269|PubMed:13525371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24924;
CC         Evidence={ECO:0000269|PubMed:13525371};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-selenocystathionine = 2-oxobutanoate + L-
CC         selenocysteine + NH4(+); Xref=Rhea:RHEA:31151, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:16763, ChEBI:CHEBI:28938, ChEBI:CHEBI:57843,
CC         ChEBI:CHEBI:62226; Evidence={ECO:0000305|PubMed:6456763};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31152;
CC         Evidence={ECO:0000305|PubMed:6456763};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-cysteine = H(+) + hydrogen sulfide + NH4(+) +
CC         pyruvate; Xref=Rhea:RHEA:24931, ChEBI:CHEBI:15361, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:28938, ChEBI:CHEBI:29919,
CC         ChEBI:CHEBI:35235; EC=4.4.1.1;
CC         Evidence={ECO:0000250|UniProtKB:P32929};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24932;
CC         Evidence={ECO:0000250|UniProtKB:P32929};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-homocysteine = 2-oxobutanoate + H(+) + hydrogen
CC         sulfide + NH4(+); Xref=Rhea:RHEA:14501, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16763, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:29919, ChEBI:CHEBI:58199; EC=4.4.1.2;
CC         Evidence={ECO:0000250|UniProtKB:P32929};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14502;
CC         Evidence={ECO:0000250|UniProtKB:P32929};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250|UniProtKB:P32929};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 8.0 with L-cystathionine.
CC         {ECO:0000305|PubMed:13525371};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-cysteine biosynthesis; L-cysteine
CC       from L-homocysteine and L-serine: step 2/2.
CC       {ECO:0000305|PubMed:13525371}.
CC   -!- SUBUNIT: Homotetramer (By similarity). Interacts with CALM in a
CC       calcium-dependent manner (By similarity).
CC       {ECO:0000250|UniProtKB:P32929, ECO:0000250|UniProtKB:Q8VCN5}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the trans-sulfuration enzymes family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D17370; BAA04189.1; -; mRNA.
DR   EMBL; X53460; CAA37547.1; -; mRNA.
DR   PIR; A49864; A49864.
DR   RefSeq; NP_058770.1; NM_017074.1.
DR   AlphaFoldDB; P18757; -.
DR   SMR; P18757; -.
DR   STRING; 10116.ENSRNOP00000058914; -.
DR   iPTMnet; P18757; -.
DR   PhosphoSitePlus; P18757; -.
DR   PaxDb; 10116-ENSRNOP00000058914; -.
DR   GeneID; 24962; -.
DR   KEGG; rno:24962; -.
DR   AGR; RGD:2443; -.
DR   CTD; 1491; -.
DR   RGD; 2443; Cth.
DR   eggNOG; KOG0053; Eukaryota.
DR   InParanoid; P18757; -.
DR   OrthoDB; 6018at2759; -.
DR   PhylomeDB; P18757; -.
DR   BioCyc; MetaCyc:MONOMER-8584; -.
DR   Reactome; R-RNO-1614558; Degradation of cysteine and homocysteine.
DR   Reactome; R-RNO-1614603; Cysteine formation from homocysteine.
DR   UniPathway; UPA00136; UER00202.
DR   PRO; PR:P18757; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004123; F:cystathionine gamma-lyase activity; ISS:UniProtKB.
DR   GO; GO:0047982; F:homocysteine desulfhydrase activity; IEA:RHEA.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0080146; F:L-cysteine desulfhydrase activity; IEA:UniProtKB-EC.
DR   GO; GO:0044540; F:L-cystine L-cysteine-lyase (deaminating); ISS:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; ISS:UniProtKB.
DR   GO; GO:0098606; F:selenocystathionine gamma-lyase activity; IEA:RHEA.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; ISO:RGD.
DR   GO; GO:0019344; P:cysteine biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0019343; P:cysteine biosynthetic process via cystathionine; ISO:RGD.
DR   GO; GO:0006749; P:glutathione metabolic process; IMP:RGD.
DR   GO; GO:0070814; P:hydrogen sulfide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; IMP:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:1904831; P:positive regulation of aortic smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; ISO:RGD.
DR   GO; GO:0044524; P:protein sulfhydration; ISS:UniProtKB.
DR   GO; GO:0018272; P:protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine; ISS:UniProtKB.
DR   GO; GO:0019346; P:transsulfuration; ISO:RGD.
DR   CDD; cd00614; CGS_like; 1.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   InterPro; IPR000277; Cys/Met-Metab_PyrdxlP-dep_enz.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   PANTHER; PTHR11808:SF15; CYSTATHIONINE GAMMA-LYASE; 1.
DR   PANTHER; PTHR11808; TRANS-SULFURATION ENZYME FAMILY MEMBER; 1.
DR   Pfam; PF01053; Cys_Met_Meta_PP; 1.
DR   PIRSF; PIRSF001434; CGS; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
DR   PROSITE; PS00868; CYS_MET_METAB_PP; 1.
PE   1: Evidence at protein level;
KW   Amino-acid biosynthesis; Calmodulin-binding; Cysteine biosynthesis;
KW   Cytoplasm; Direct protein sequencing; Lipid metabolism; Lyase;
KW   Phosphoprotein; Pyridoxal phosphate; Reference proteome.
FT   CHAIN           1..398
FT                   /note="Cystathionine gamma-lyase"
FT                   /id="PRO_0000114752"
FT   BINDING         61
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         113
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         118
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         338
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         50
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         211
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32929"
FT   CONFLICT        35..41
FT                   /note="AVVLPIS -> CCGAAH (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="T -> N (in Ref. 2; CAA37547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        260..271
FT                   /note="TLQIRMEKHFRN -> HCRSGWRNTFQD (in Ref. 2; CAA37547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        305..308
FT                   /note="QCTG -> SARA (in Ref. 2; CAA37547)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   398 AA;  43605 MW;  C6043988B03D725F CRC64;
     MQKDASSSGF LPSFQHFATQ AIHVGPEPEQ WSSRAVVLPI SLATTFKQDS PGQSSGFVYS
     RSGNPTRNCL EKAVAALDGA KHCLTFARGL AATTTITHLL KAGDEVICMD EVYGGTNRYF
     RRVASEFGLK ISFVDCSKTK LLEAAITPQT KLVWIETPTN PTLKLADIKA CAQIVHKHKD
     IILVVDNTFM SAYFQRPLAL GADICMCSAT KYMNGHSDVV MGLVSVTSDD LNERLRFLQN
     SLGAVPSPFD CYLCCRGLKT LQIRMEKHFR NGMAVARFLE SNPRVEKVIY PGLPSHPQHE
     LAKRQCTGCP GMVSFYIKGT LQHAQVFLKN IKLFALAESL GGYESLAELP AIMTHASVPE
     KDRATLGISD TLIRLSVGLE DEKDLLEDLG QALKAAHP
//
